ONCY:NASDAQ
Oncolytics Biotech Inc
$0.84
arrow_downward
-3.55%(-0.031) 1D
$0.85
arrow_upward
+1.35% (+0.011)bedtimeAfter hours
Closed: Jun 5, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ONCY...
Open
$0.86
High
$0.86
Low
$0.83
Mkt. cap
99.80M
Avg. vol.
1.50M
Volume
1.05M
52-wk high
$1.51
52-wk low
$0.33
Beta
1.07
Shares outstanding
119.35M
No. of employees
29
Open
$0.86
High
$0.86
Low
$0.83
Mkt. cap
99.80M
Avg. vol.
1.50M
Volume
1.05M
52-wk high
$1.51
52-wk low
$0.33
Beta
1.07
Shares outstanding
119.35M
No. of employees
29
Analyst outlook
Analyst Ratings
Based on 4 analysts giving stock ratings to ONCY in the past 3 months
Strong Buy
Buy
3
Hold
1
Sell
0
12 month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ONCY in the last 3 months.
Highest
Current $0.84
$10.00 (+1,095.89%)
Average
$6.00 (+617.53%)
Lowest
$3.00 (+258.77%)
News stories
From sources across the web
Yahoo Finance
·
2 days ago
Oncolytics Biotech (ONCY) Valuation Check As New Pelareorep RAS Combo Data Draws Investor Attention
Stock Titan
·
2 days ago
145,000 stock options granted to Oncolytics (ONCY) COO McAdory
Profile
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
About Oncolytics Biotech Inc
CEO-
Employees29
Founded1998
HeadquartersCalgary, Alberta, Canada
SectorBiotechnology
Websiteoncolyticsbiotech.com
AI content may include mistakes. Learn more